Angiotensin-(1-7) attenuates damage to podocytes induced by preeclamptic serum through MAPK pathways

Tian,Jimei; Zhang,Lihong; Zhou,Yunjiao; Xiao,Jing; Li,Sheran; Chen,Yaping; Qiao,Zhongdong; Niu,Jianying; Gu,Yong

doi:10.3892/ijmm.2014.1870

Angiotensin-(1-7) attenuates damage to podocytes induced by preeclamptic serum through MAPK pathways

Authors:
- Jimei Tian
- Lihong Zhang
- Yunjiao Zhou
- Jing Xiao
- Sheran Li
- Yaping Chen
- Zhongdong Qiao
- Jianying Niu
- Yong Gu
View Affiliations

Affiliations: Division of Nephrology, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, P.R. China, Department of Gynaecology and Obstetrics, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, P.R. China, School of Life Science and Biotechnology, Shanghai Jiaotong University, Shanghai, P.R. China
Published online on: July 29, 2014 https://doi.org/10.3892/ijmm.2014.1870
Pages: 1057-1064

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The underlying mechanisms of proteinuria, a main characteristic of preeclampsia (PE), have not yet been fully elucidated. Evidence indicates that the renin-angiotensin system (RAS) is involved in the pathogenesis of this disease, including decreased angiotensin-(1-7) [Ang-(1-7)] levels in the circulation and urine. In the present study, we examined the damage to podocytes induced by preeclamptic serum and the effects of Ang-(1-7) on podocytes treated with preeclamptic serum, as well as the underlying mechanisms. The podocytes were incubated with serum obtained from women with PE or with serum from women with normal pregnancies for different periods of time. Cell viability was determined by CCK-8 assay. The cells were treated with various concentrations of Ang-(1-7) and A779 [an (Ang-(1-7) antagonist]. The effects of Ang-(1-7) on the expression of podocyte-specific proteins [nephrin, Wilms tumor‑1 (WT-1) and podocin] and the phosphorylation of mitogen-activated protein kinases (MAPKs) were investigated by western blot analysis. Changes in F-actin rearrangement were determined by immunofluorescence. Podocyte apoptosis was determined by flow cytometry. The results revealed that in the cultured podocytes incubated with preeclamptic serum, there was a decrease in the expression of podocyte-specific proteins (nephrin and WT-1 but not podocin), a rearrangement of F-actin and apoptosis compared with the control group. However, treatment with Ang-(1-7) attenuated podocyte injury in the preeclamptic group, which may be mediated through the downregulation of MAPK (p38, ERK1/2 and JNK) phosphorylation. Thus, our data suggest that Ang-(1-7) plays a protective role in PE through the downregulation of MAPK phosphorylation.

View Figures

View References

1	Walker JJ: Pre-eclampsia. Lancet. 356:1260–1265. 2000. View Article : Google Scholar : PubMed/NCBI
2	Jones DC and Hayslett JP: Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med. 335:226–232. 1996. View Article : Google Scholar : PubMed/NCBI
3	Levine RJ, Maynard SE, Qian C, et al: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 350:672–683. 2004. View Article : Google Scholar : PubMed/NCBI
4	Garovic VD, Wagner SJ, Petrovic LM, et al: Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant. 22:1136–1143. 2007. View Article : Google Scholar : PubMed/NCBI
5	Herman-Edelstein M, Weinstein T and Gafter U: TGFβ1-dependent podocyte dysfunction. Curr Opin Nephrol Hypertens. 22:93–99. 2013.
6	Shah DM: Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol. 288:F614–F625. 2005. View Article : Google Scholar : PubMed/NCBI
7	Irani RA and Xia Y: Renin angiotensin signaling in normal pregnancy and preeclampsia. Semin Nephrol. 31:47–58. 2011. View Article : Google Scholar : PubMed/NCBI
8	Anton L and Brosnihan KB: Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies. Ther Adv Cardiovasc Dis. 2:349–362. 2008. View Article : Google Scholar : PubMed/NCBI
9	Valdes G, Germain AM, Corthorn J, et al: Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine. 16:117–122. 2001. View Article : Google Scholar : PubMed/NCBI
10	Santos RA, Ferreira AJ, Pinheiro SV, Sampaio WO, Touyz R and Campagnole-Santos MJ: Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs. Expert Opin Investig Drugs. 14:1019–1031. 2005. View Article : Google Scholar : PubMed/NCBI
11	Merrill DC, Karoly M, Chen K, Ferrario CM and Brosnihan KB: Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine. 18:239–245. 2002. View Article : Google Scholar : PubMed/NCBI
12	Herse F, Staff AC, Hering L, Muller DN, Luft FC and Dechend R: AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia. J Mol Med (Berl). 86:697–703. 2008. View Article : Google Scholar : PubMed/NCBI
13	Abdul-Karim R and Assalin S: Pressor response to angiotonin in pregnant and nonpregnant women. Am J Obstet Gynecol. 82:246–251. 1961.PubMed/NCBI
14	Su Z, Zimpelmann J and Burns KD: Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int. 69:2212–2218. 2006. View Article : Google Scholar : PubMed/NCBI
15	Gava E, Samad-Zadeh A, Zimpelmann J, et al: Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells. Nephrol Dial Transplant. 24:1766–1773. 2009. View Article : Google Scholar : PubMed/NCBI
16	Velez JC, Bland AM, Arthur JM, Raymond JR and Janech MG: Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol. 293:F398–F407. 2007. View Article : Google Scholar : PubMed/NCBI
17	Zimmerman D and Burns KD: Angiotensin-(1-7) in kidney disease: a review of the controversies. Clin Sci (Lond). 123:333–346. 2012. View Article : Google Scholar : PubMed/NCBI
18	Saleem MA, O’Hare MJ, Reiser J, et al: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol. 13:630–638. 2002.PubMed/NCBI
19	Moller CC, Wei C, Altintas MM, et al: Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol. 18:29–36. 2007. View Article : Google Scholar : PubMed/NCBI
20	Pavenstadt H, Kriz W and Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev. 83:253–307. 2003.
21	Tryggvason K, Pikkarainen T and Patrakka J: Nck links nephrin to actin in kidney podocytes. Cell. 125:221–224. 2006. View Article : Google Scholar : PubMed/NCBI
22	Kriz W, Gretz N and Lemley KV: Progression of glomerular diseases: is the podocyte the culprit? Kidney Int. 54:687–697. 1998. View Article : Google Scholar : PubMed/NCBI
23	Chen G, Zhang L, Jin X, et al: Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia. Reprod Sci. 20:579–588. 2013. View Article : Google Scholar : PubMed/NCBI
24	Giani JF, Munoz MC, Pons RA, et al: Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats. Am J Physiol Renal Physiol. 300:F272–F282. 2011. View Article : Google Scholar : PubMed/NCBI
25	Benter IF, Yousif MH, Anim JT, Cojocel C and Diz DI: Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Am J Physiol Heart Circ Physiol. 290:H684–H691. 2006. View Article : Google Scholar : PubMed/NCBI
26	Shao Y, He M, Zhou L, Yao T, Huang Y and Lu LM: Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury. Acta Pharmacol Sin. 29:829–837. 2008. View Article : Google Scholar : PubMed/NCBI
27	Moon JY, Tanimoto M, Gohda T, et al: Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice. Am J Physiol Renal Physiol. 300:F1271–F1282. 2011. View Article : Google Scholar
28	Zimpelmann J and Burns KD: Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells. Am J Physiol Renal Physiol. 296:F337–F346. 2009. View Article : Google Scholar : PubMed/NCBI